LIPO · Lipella Pharmaceuticals Inc. · Investor Relations
$0.00
At close · Nov 11
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These factors individually and collectively raise substantial doubt about the Company's ability to continue as a going concern. The accompanying unaudited condensed financial statements do not include any adjustments that may result from this uncertainty.”View the 10-Q filed Nov 14, 2025
Market Cap
$2,773
Shares
4.62M
Volume · Nov 11
43.34K
Avg daily vol (3M)
3997
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2025-09-18 | Zacks SCR Life Sciences Virtual Investor September 18th, 2025 at 12:30pm EDT. | Event |
Source: https://ir.lipella.com/